CollPlant Biotechnologies (FRA:CPT) Cyclically Adjusted Book per Share: €1.63 (As of Mar. 2026)


FRA:CPT CollPlant Biotechnologies Ltd FRA:CPT
22 GF Score
Price €0.27
GF Value €0.23
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is CollPlant Biotechnologies Cyclically Adjusted Book per Share?

CollPlant Biotechnologies FRA:CPT 22 Cyclically Adjusted Book per Share is €1.63 as of Mar. 2026. GuruFocus rates FRA:CPT with a GF Score™ of 22/100 and a GF Value™ of €0.23 (Modestly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

CollPlant Biotechnologies's adjusted book value per share for the three months ended in Mar. 2026 was €0.293. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.63 for the trailing ten years ended in Mar. 2026.

During the past 12 months, CollPlant Biotechnologies's average Cyclically Adjusted Book Growth Rate was -4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-06), CollPlant Biotechnologies's current stock price is €0.266. CollPlant Biotechnologies's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €1.63. CollPlant Biotechnologies's Cyclically Adjusted PB Ratio of today is 0.16.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of CollPlant Biotechnologies was 2.99. The lowest was 0.16. And the median was 1.44.


CollPlant Biotechnologies  (FRA:CPT) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

CollPlant Biotechnologies's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.266/1.63
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of CollPlant Biotechnologies was 2.99. The lowest was 0.16. And the median was 1.44.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


CollPlant Biotechnologies Cyclically Adjusted Book per Share Related Terms


CollPlant Biotechnologies Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for CollPlant Biotechnologies's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CollPlant Biotechnologies Cyclically Adjusted Book per Share Chart

CollPlant Biotechnologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 1.80 1.68

CollPlant Biotechnologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.56 1.72 1.94 1.68 1.63

FRA:CPT vs CPMV, TCRT, DRMA: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, CollPlant Biotechnologies's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CollPlant Biotechnologies Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CollPlant Biotechnologies's Cyclically Adjusted PB Ratio falls into.


FRA:CPT
22GF Score
CollPlant Biotechnologies Ltd FRA:CPT
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CollPlant Biotechnologies Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CollPlant Biotechnologies's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.293/330.2130*330.2130
=0.293

Current CPI (Mar. 2026) = 330.2130.

CollPlant Biotechnologies Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.764 241.018 2.417
201609 1.277 241.428 1.747
201612 0.588 241.432 0.804
201703 0.876 243.801 1.186
201706 0.489 244.955 0.659
201709 0.172 246.819 0.230
201712 0.662 246.524 0.887
201803 1.181 249.554 1.563
201806 0.864 251.989 1.132
201809 0.836 252.439 1.094
201812 1.249 251.233 1.642
201903 0.720 254.202 0.935
201906 0.424 256.143 0.547
201909 -0.232 256.759 -0.298
201912 0.649 256.974 0.834
202003 1.018 258.115 1.302
202006 0.793 257.797 1.016
202009 0.888 260.280 1.127
202012 0.528 260.474 0.669
202103 4.291 264.877 5.349
202106 4.000 271.696 4.862
202109 3.854 274.310 4.639
202112 3.707 278.802 4.391
202203 3.538 287.504 4.064
202206 3.371 296.311 3.757
202209 3.262 296.808 3.629
202212 2.724 296.797 3.031
202303 2.452 301.836 2.683
202306 2.917 305.109 3.157
202309 2.651 307.789 2.844
202312 2.269 306.746 2.443
202403 1.963 312.332 2.075
202406 1.681 314.175 1.767
202409 1.331 315.301 1.394
202412 1.123 315.605 1.175
202503 1.001 319.799 1.034
202506 0.853 322.561 0.873
202509 0.621 324.800 0.631
202512 0.406 324.054 0.414
202603 0.293 330.213 0.293

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €1.63 mean?
CollPlant Biotechnologies (FRA:CPT) has a Cyclically Adjusted Book per Share of €1.63 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on CollPlant Biotechnologies and its competitors.
Is CollPlant Biotechnologies' Cyclically Adjusted Book per Share too high?
CollPlant Biotechnologies' current Cyclically Adjusted Book per Share is €1.63. Overall, CollPlant Biotechnologies has a GF Score™ of 22/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CollPlant Biotechnologies' Cyclically Adjusted Book per Share compare to CPMV and TCRT?
CollPlant Biotechnologies' Cyclically Adjusted Book per Share of €1.63 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on CollPlant Biotechnologies and its competitors. CollPlant Biotechnologies's current Cyclically Adjusted Book per Share is €1.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CollPlant Biotechnologies stock overvalued right now?
Based on GuruFocus' analysis, CollPlant Biotechnologies (FRA:CPT) is currently considered Modestly Overvalued. The stock's GF Value™ is €0.23, compared to a current price of €0.27 — trading 15.7% above its estimated fair value. The current Cyclically Adjusted Book per Share is €1.63. CollPlant Biotechnologies' overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For CollPlant Biotechnologies (FRA:CPT), the current Cyclically Adjusted Book per Share is €1.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CollPlant Biotechnologies (FRA:CPT) Overvalued in 2026?

Based on GuruFocus' analysis, CollPlant Biotechnologies stock appears to be overvalued. The current stock price of €0.27 is trading 15.7% above its estimated GF Value™ of €0.23. GuruFocus considers CollPlant Biotechnologies to be Modestly Overvalued.

Key valuation signals for FRA:CPT:

  • Cyclically Adjusted Book per Share: €1.63
  • GF Value™: €0.23 vs. price of €0.27 (15.7% above fair value)
  • GF Score™: 22/100 with 4 warning signs

No single metric tells the full story. See the FRA:CPT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CollPlant Biotechnologies Business Description

Other Exchanges CLGN:USA
Address 4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
22GF Score

Get the complete analysis for FRA:CPT

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price
€0.23
GF Value